| Field | Specification |
|---|---|
| Mfr No | |
| Clonality | |
| Host | |
| Immunogen | Peptide derived from N-terminal sequence of human C3d complement fragment |
| Isotype | |
| Product Type | |
| Reactivity | |
| Target |
Product Overview
IHC Primary AntibodyIHC-optimized antibody targeting C3d complement. Designed for paraffin-embedded tissue sections (IHC-P). Validated for use at 1:100 dilution.
Validated Application
| Application | Recommended Dilution |
|---|---|
| Immunohistochemistry – Paraffin (IHC-P) | 1:100 |
Antibody Specifications
| Target | C3d complement |
|---|---|
| Host | Rabbit |
| Clonality | Monoclonal |
| Isotype | IgG |
| Conjugate | Unconjugated |
| Reactivity | Human |
| Purification | Affinity Purification |
| Immunogen | Peptide derived from N-terminal sequence of human C3d complement fragment |
| Clone | E28-P |
| UniProt | P01024 |
| Stabilizer | 20 mg/ml BSA |
| Preservative | 0.05% NaN3 |
| Formulation | nan |
| Storage Buffer | 20 mM Tris-HCl, pH 8.0 |
| Storage | nan |
Safety & Handling
| Target | C3d complement |
| Host | Rabbit |
| Clonality | Monoclonal |
| Conjugate | Unconjugated |
| Reactivity | Human |
| Application | IHC-P |
| Dilution | 1:100 |
| Purification | Affinity Purification |
| Clone | E28-P |
| Immunogen | Peptide derived from N-terminal sequence of human C3d complement fragment |
Validated for IHC-P on paraffin-embedded sections.
| Application | Dilution |
|---|---|
| IHC-P (Paraffin) | 1:100 |
Immunogen: Peptide derived from N-terminal sequence of human C3d complement fragment
Clone: E28-P
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
